Speakers Introduction

Dr. Alan Russell (Ph.D., Imperial College) is Vice President of Research (Large Molecule Discovery & Data Science) and Head of R&D Technology & Innovation at Amgen Inc. He leads global teams focused on large molecule therapeutics and the application of data science across R&D. He champions talent development, safety, and innovation.

Previously, Alan was the Highmark Distinguished Career Professor at Carnegie Mellon University and Director of the Disruptive Health Technology Institute. From 2012 to 2016, he also served as Executive Vice President and Chief Innovation Officer at Allegheny Health Network. He founded Agentase LLC (acquired by FLIR/Teledyne), led BioHybrid Solutions as CEO, and chaired YouScript and Rheogene, both acquired. He was the founding director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh (2001–2011).

Alan’s passion at the interface of regulation and science led to him serving on the FDA Science Board for a decade, chairing its major review of the Center for Devices and Radiologic Health. His research spans chemical and polymer synthesis, tissue engineering, and homeland defense, earning a US Army “Greatest Invention” award. He has founded four companies, delivered over 500 invited lectures, authored 250+ peer-reviewed papers (20,000+ citations), and holds numerous patents worldwide.